For those that haven't seen this and potential investors. This is Dr Andrew Stephens, the Research Group Head, Ovarian Cancer Biomarkers, at Hudson Institute. GLTAH
Interview with Dr Andrew Stephens at Hudson Institute - Proof-of-Concept Cancer treatment
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
-0.010(7.41%) |
Mkt cap ! $10.59M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 14.0¢ | 12.5¢ | $59.92K | 456.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 48324 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 11.45am 16/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |